Genesis Therapeutics

Overview

Builds molecular AI models and a design platform to optimize small-molecule drug discovery and create new medicines for partners and internal programs.

Part of the Silicon Valley ecosystem

Related

• 8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
• a16z Bio + HealthInvests in seed through growth-stage bio and healthcare technology companies, supporting founders developing medical breakthroughs, disease-focused approaches, and infrastructure for modern healthcare.
• Chai DiscoveryBuilds computer-aided molecular design software that models biochemical structure and interaction, helping scientists design new medicines and molecules on computers.
• DCVCInvests in entrepreneurs using AI and computational approaches to address difficult real-world problems across sectors, with a related bio effort for computational biology.
• In-Q-TelBuilds a nonprofit investment platform that identifies strategic technology startups and adapts their technologies to meet current and future government partner mission needs.
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics across multiple drug modalities.
• MedraBuilds autonomous AI robotic lab systems that collect life science data and design, execute, interpret, and improve experiments in closed loops.
• Merge LabsCollect visitor inquiries and email list sign-ups through a launch landing page, enabling updates, promotions, and direct contact before the site opens.
• NewLimitDevelops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related cellular decline and human healthspan.
• Numerion LabsBuilds an AI platform that searches chemical space for novel drug-like molecules, supporting small-molecule drug discovery programs for immune and inflammatory diseases.
• ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design applications.
• Stanford UniversityEducates students, conducts interdisciplinary research, develops technologies, supports human health, and applies policy work to address societal needs and benefit humanity.